Top compounds associated with response to RRAGC


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 3e-05
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 6e-05
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.13 0.0002
mRNA BMS-754807 GDSC1000 pan-cancer AAC -0.13 0.0002
mRNA BRD-K03911514 CTRPv2 pan-cancer AAC 0.19 0.0003
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0004
mRNA lapatinib CCLE pan-cancer AAC -0.16 0.0007
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0007
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0009
mRNA EKB-569 GDSC1000 pan-cancer AAC -0.11 0.001
Download CSV